| Secondary |
| Drug Use For Unknown Indication |
16.6% |
| Product Used For Unknown Indication |
15.6% |
| Suicide Attempt |
10.6% |
| Pain |
8.5% |
| Hypertension |
5.0% |
| Analgesia |
4.5% |
| Arthralgia |
4.5% |
| Thermal Burn |
4.0% |
| Urinary Tract Infection |
4.0% |
| Analgesic Therapy |
3.5% |
| Back Pain |
3.5% |
| Depression |
3.0% |
| Antibiotic Therapy |
2.5% |
| Pneumonia |
2.5% |
| Hypercalcaemia |
2.0% |
| Prophylaxis |
2.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.0% |
| Pyelonephritis Acute |
2.0% |
| Sleep Disorder |
2.0% |
| Bursitis |
1.5% |
|
| Hepatic Lesion |
8.7% |
| Hepatitis Fulminant |
8.7% |
| Pleural Effusion |
8.7% |
| Renal Failure Acute |
8.7% |
| Thrombocytopenia |
8.7% |
| Suicide Attempt |
6.5% |
| Urticaria |
6.5% |
| Haemoglobin Decreased |
4.3% |
| Hepatitis |
4.3% |
| Hepatotoxicity |
4.3% |
| Pseudomembranous Colitis |
4.3% |
| Sciatica |
4.3% |
| Skin Exfoliation |
4.3% |
| Somnolence |
4.3% |
| Acidosis |
2.2% |
| Blood Creatinine Increased |
2.2% |
| Drug Interaction |
2.2% |
| Liver Injury |
2.2% |
| Megacolon |
2.2% |
| Overdose |
2.2% |
|
| Concomitant |
| Pain |
20.6% |
| Drug Use For Unknown Indication |
19.0% |
| Prophylaxis |
14.8% |
| Osteoporosis |
7.0% |
| Product Used For Unknown Indication |
5.1% |
| Non-small Cell Lung Cancer |
4.8% |
| Hypertension |
3.7% |
| Renal Cancer |
3.7% |
| Depression |
3.3% |
| Non-small Cell Lung Cancer Stage Iii |
2.5% |
| Renal Cell Carcinoma |
2.5% |
| Oesophagitis |
2.1% |
| Gastric Disorder |
1.9% |
| Autoimmune Hepatitis |
1.4% |
| Gouty Arthritis |
1.4% |
| Small Cell Lung Cancer Stage Unspecified |
1.4% |
| Analgesic Therapy |
1.2% |
| Insomnia |
1.2% |
| Rheumatoid Arthritis |
1.2% |
| Deep Vein Thrombosis |
1.1% |
|
| Tumour Haemorrhage |
12.9% |
| Vomiting |
10.0% |
| Pleural Effusion |
8.6% |
| Respiratory Failure |
7.1% |
| Thrombocytopenia |
7.1% |
| Asthenia |
4.3% |
| Colon Cancer |
4.3% |
| Device Related Infection |
4.3% |
| Peripheral Ischaemia |
4.3% |
| Petechiae |
4.3% |
| Pharyngolaryngeal Pain |
4.3% |
| Pneumonitis |
4.3% |
| Transaminases Increased |
4.3% |
| Arthritis |
2.9% |
| Cartilage Injury |
2.9% |
| Fall |
2.9% |
| Metrorrhagia |
2.9% |
| Neutropenia |
2.9% |
| Scoliosis |
2.9% |
| Systemic Lupus Erythematosus |
2.9% |
|
| Interacting |
| Back Pain |
23.1% |
| Pain |
19.2% |
| Hypertension |
15.4% |
| Prophylaxis |
11.5% |
| Type 2 Diabetes Mellitus |
11.5% |
| Cardiac Failure |
7.7% |
| Drug Use For Unknown Indication |
3.8% |
| Hyperlipidaemia |
3.8% |
| Muscle Contracture |
3.8% |
|
| Drug Interaction |
33.3% |
| Gastrointestinal Haemorrhage |
16.7% |
| Hypotension |
16.7% |
| Renal Failure |
16.7% |
| Renal Failure Acute |
16.7% |
|
